11/08/2024
5:22 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
5:13 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
12:54 PM | VANGUARD GROUP INC (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
5:31 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
8:48 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
3:37 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
6:27 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/25/2024
6:28 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
3:10 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
4:00 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2024
3:09 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
11:26 AM | STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A | |
09/20/2024
8:20 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
8:21 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
3:29 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
6:23 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
6:23 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
7:11 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
7:13 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
7:00 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
6:47 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
7:03 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:38 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
3:05 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:05 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:05 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
4:55 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
4:56 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
4:58 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
4:00 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024
3:10 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
6:10 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
6:46 PM | Viking Therapeutics (Filer)
| Form S-8 POS | |
05/22/2024
6:54 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
3:33 PM | Viking Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/03/2024
7:51 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
3:04 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
8:27 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
3:02 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/24/2024
7:42 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
3:05 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Urgent: Monday is the last day to start collecting up to $4,243 in monthly dividends (Ad) You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors.
Registration to collect your first payout closes this week, so you are advised to sign up today. Click here to find out more and get started. |
04/05/2024
3:15 PM | Viking Therapeutics (Filer)
| Form ARS | |
03/27/2024
7:50 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
7:51 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
7:52 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
6:08 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
6:50 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:52 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:54 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:52 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
3:05 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
4:21 PM | Viking Therapeutics (Filer)
| Form 424B5 | |
02/27/2024
6:04 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
7:59 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:38 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:40 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
4:24 PM | Viking Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/07/2024
4:33 PM | Viking Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/31/2024
7:39 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:32 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
8:05 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:23 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
12:24 PM | STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A | |
01/19/2024
7:35 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:36 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
3:26 PM | MILLENNIUM MANAGEMENT LLC (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A | |
01/04/2024
8:35 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:36 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:37 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:22 PM | FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:24 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:25 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:27 PM | Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:28 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
7:12 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
